Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges

Fabrizio Tediosi; Peter Steinmann; Don de Savigny; Marcel Tanner

doi:10.1371/journal.pntd.0002446

Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges

PLoS Negl Trop Dis. 2013 Nov 7;7(11):e2446. doi: 10.1371/journal.pntd.0002446. eCollection 2013 Nov.

Authors

Fabrizio Tediosi¹, Peter Steinmann, Don de Savigny, Marcel Tanner

Affiliation

¹ Swiss Tropical and Public Health Institute, Basel, Switzerland ; University of Basel, Basel, Switzerland.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Elephantiasis, Filarial / prevention & control*
Global Health / economics
Humans
Onchocerciasis / prevention & control*
Trypanosomiasis, African / prevention & control*

Grants and funding

Project supported by the Bill and Melinda Gates Foundation – Grant number OPP1037660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.